Both in Biotechnology
Kymera Therapeutics vs Neurocrine Biosciences
Over the past year KYMR returned +112.0% and NBIX returned +2.9%; their daily moves had a correlation of 0.22.
KYMR +112.0% NBIX +2.9%Growth of $1, one year, split-adjusted
| Metric | KYMR | NBIX |
|---|---|---|
| Price | $126.63 | $146.10 |
| Market cap | $10.81B | $14.85B |
| Today | +3.29% | −0.19% |
| 1 month | +15.0% | +3.8% |
| 6 months | +56.9% | +10.9% |
| Year to date | +62.7% | +3.0% |
| 1 year | +110.9% | +5.9% |
| Revenue growth (YoY) | −100.0% | +39.5% |
| Gross margin | — | 97.6% |
| Net margin | — | 15.1% |
| P/E (TTM) | — | 21.1× |
| Price / sales | 105.7× | 4.4× |
| Net cash | $969.2M | $389.8M |
| Dividend yield | — | — |
| Volatility (60d) | 38.9% | 26.3% |
| Short % of float | 13.7% | 6.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).